Clinical Trial: Safety, Tolerability, PK, and PD of TGM-148 in Healthy Participants

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843368) titled 'Safety, Tolerability, PK, and PD of TGM-148 in Healthy Participants' on Sept. 21.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) effects of single ascending doses of TGM-148 in healthy adults

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: TGM-148

TGM-148 is an investigational medicinal product administered by subcutaneous injection according to a protocol-defined regimen.

DRUG: Placebo

Placebo administered by subcutaneous injection according to a protocol-defined regimen.

Recruitm...